MMJ Recs

APRIL 1, 2024

In recent years, the spotlight on CBD (cannabidiol) within medical marijuana has intensified, with researchers and medical professionals delving deeper into its potential therapeutic benefits. CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

Medical Marijuana Program Connection

FEBRUARY 28, 2023

Incannex Healthcare Limited IXHL IHL has commenced a phase 2 clinical trial to assess the safety and efficacy of its. Read More

Clinical Trials 40

Clinical Trials Treatment Safety CBD 40

The Fresh Toast

JULY 22, 2020

Marijuana Shows Promise In Sickle Cell Disease Treatment. Clinical trial results indicate cannabis could provide an alternative or adjunctive treatment to sickle cell patients. The post Marijuana Shows Promise In Sickle Cell Disease Treatment appeared first on The Fresh Toast.

Treatment 105

Treatment Clinical Trials Marijuana Patients 105

Puff Puff Post

MARCH 10, 2020

” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

AUGUST 23, 2021

We presume the angle is getting liberal party members to give approval and buy stock at the same time so they can all get rich selling placebo CBD to all those idiots who refuse to get vaccinated for COVID. The treatment was generally well tolerated and the median reduction in seizures was 81.9% following 12 weeks of treatment.

Clinical Trials 105

Clinical Trials CBD Epilepsy Treatment 105

Veriheal

SEPTEMBER 18, 2020

Conventional forms of treatment are often accompanied by adverse side effects but there is hope for effective treatment with fewer side effects. . Research Team to Study the Impact of CBD on Spinal Injury Pain. Lambert Initiative experts have won $1.7 Lambert Initiative experts have won $1.7 Along with the $1.7

Treatment 98

Treatment Chronic Pain Research and Development CBD 98

Medical Marijuana Program Connection

MARCH 14, 2023

The University of Nebraska Medical Center (UNMC) and ANANDA Scientific Inc. announced that the first patient has been enrolled in. Read More

Clinical Trials 52

Clinical Trials Patients Treatment CBD 52

The Joint Blog

JULY 13, 2023

Classified as a neurological disorder, typical treatments include neuropathic painkillers that come with unpleasant side effects. Finding a natural alternative to these strong pharmaceuticals- one that doesn’t come with such downsides- could improve the lives of many sufferers.

Treatment 47

Treatment CBD Clinical Trials Stress Management 47

Medical Marijuana Program Connection

FEBRUARY 27, 2023

The cannabis oil will be used as a part of the Company‘s proprietary SCI-210 treatment combination of CBD and CannAmide™ TEL. Read More

Clinical Trials 52

Clinical Trials Oil CBD Treatment 52

Medical Marijuana Program Connection

JANUARY 16, 2024

Rowena Naylor/Stocksy United Cannabidiol (CBD) has been approved for use in the treatment of two early-onset, intractable forms of epilepsy, Dravet syndrome and Lennox-Gastaut syndrome, since 2018. This decision followed clinical trials showing. Read More

Clinical Trials 40

Clinical Trials CBD Epilepsy Treatment 40

Cannabis Law Report

AUGUST 26, 2022

The desire to understand the role of CBD in the body has never been greater. CBD has been suggested to act as a treatment for sclerosis symptoms, as well as epilepsy among children. Apart from this, various clinical trials are done for multiple conditions. One of these is the use of CBD. Hormonal changes.

Epilepsy 52

Epilepsy Treatment CBD Sleep 52

FloridaMarijuana.net

AUGUST 15, 2018

Treatment usually aims at reducing reactions and to diminishing the acuity of the reactions. Treatments also seek to increase the subject’s ability to manage trauma-related emotions and to greater confidence in coping abilities. The post Medical Marijuana Offers Hope for Treatment of PTSD appeared first on.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. CBD for hypertension. Related story Can CBD Help Your Condition? The results were mixed.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Project CBD

OCTOBER 10, 2019

Two compounds that target the endocannabinoid system are currently in development to treat scleroderma – and they’re already in clinical trials. Referred to as a “selective CB2 agonist ,” such a compound would appear to have potential as a treatment for scleroderma.

Cannabinoids 224

Cannabinoids Clinical Trials Research and Development Pharmaceutical 224

Cannabis Life Network

MAY 27, 2021

Early scientific research and clinical trials have shown promise in their ability to help supplement treatments for people with various neurological disorders with cannabidiol (CBD). CBD is a naturally occurring chemical compound found in cannabis, such as hemp.

Clinical Trials 76

Clinical Trials CBD Treatment Hemp 76

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

In either case, there is definitely a connection, and the widening availability for adults to consume cannabis legally for recreational and medicinal purposes has driven public interest into using cannabis for mental health treatment. CBD seems to help the body’s natural endocannabinoid system return to normalcy and function better.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. CBD for hypertension. Related story Can CBD Help Your Condition? The results were mixed.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

The Joint Blog

NOVEMBER 8, 2020

mg of CBD (both very low numbers). We conclude that phytocannabinoids can be a low-cost and well-tolerated therapy for symptom relief and quality of life improvement in these patients, and we suggest that this therapy could be included as an herbal medicine option for the treatment of this condition in the Brazilian public health system.”.

Clinical Trials 49

Clinical Trials Oil Therapy Marijuana 49

Veriheal

MARCH 2, 2024

In December of 2023, the country recently made a new move towards reform that could stimulate the cannabidiol (CBD) industry and provide many patients, such as those with epilepsy , with access to potentially life-changing medical treatments. and Europe to treat severe epilepsy, as well as other medical conditions.

Legalization 106

Legalization Epilepsy Clinical Trials THC 106

LifeCannMD

FEBRUARY 27, 2024

CBD’s ability to reduce glutamate levels and enhance GABA activity can help to reduce seizures. The most compelling evidence of the effectiveness of Medical Marijuana in treating epilepsy comes from clinical trials. These studies have led to the approval of Epidiolex by the U.S.

Clinical Trials 59

Clinical Trials Epilepsy Marijuana Research and Development 59

Cannabis Law Report

OCTOBER 15, 2021

(USOTC: PAOG) cited a British Medical Journal case study report published today on the effectiveness of CBD in the treatment of lung cancer and COPD as validation of PAOG’s ongoing research and development of its own respiratory disorder treatment under the name RespRx. 9,199,960). USOTC: USMJ). Billion by 2027.

Treatment 52

Treatment Research and Development CBD eCommerce 52

Cannabis Law Report

SEPTEMBER 13, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021. in the blood. For more information, visit www.mymd.com.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

Project CBD

MARCH 21, 2023

For the next couple days, she got extra sleep to aid recovery, and for good measure took an extra dose or two of CBD. The CBD she took may or may not have helped, but according to a recent survey of tinnitus patients, she wasn’t alone in trying — or at least in being interested in cannabis as a potential remedy.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

PrestoDoctor

OCTOBER 11, 2023

One area of research that has been gaining attention is the use of CBD-rich cannabis in treating the social symptoms of Autism Spectrum Disorder (ASD). Studies have shown that CBD-rich cannabis can help alleviate symptoms such as anxiety, aggression, and social isolation in individuals with ASD. What is CBD?

CBD 52

CBD Research and Development Clinical Trials Treatment 52

Puff Puff Post

MARCH 10, 2020

” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

AUGUST 6, 2021

CBD, which is an abbreviation for Cannabidiol, is one of Cannabis’s primary components – one of its primary Cannabinoids. CBD does not give its users the ‘high’ typically associated with Cannabis. In this article, we’ll tell you what some of the top health benefits of CBD products are: Mental Health Disorders. Analgesic Effects.

CBD 105

CBD Wellness and Beauty Treatment Pharmaceutical 105

The Cannigma

JANUARY 24, 2021

Researchers at the University of Queensland have, for the first time, shown that a form of synthetic cannabidiol (CBD) can kill the bacteria responsible for gonorrhea, meningitis, and Legionnaire’s disease. A first for CBD. A future drug?

CBD 125

CBD Clinical Trials Treatment Pharmaceutical 125

MMJ Recs

NOVEMBER 20, 2023

While there are over 100 different cannabinoids identified in cannabis, the two most well-known and widely studied are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). On the other hand, CBD is non-psychoactive and has gained attention for its potential therapeutic applications.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Veriheal

AUGUST 22, 2022

Clinical trials into cannabis’ potential as an opioid replacement are well underway in South Africa. Quite frankly, the clinical trials couldn’t have come at a better time. The flower contained high levels of THC in the range of 15-25 milligrams, with CBD content resting on the lower end of the spectrum at 0.5

Clinical Trials 113

Clinical Trials Chronic Pain Hydroponic Strains 113

The Joint Blog

FEBRUARY 11, 2022

We’ve known for quite a while that CBD offers very real health benefits for consumers. With more corners of the world coming around and legalizing the use of CBD for research and treatment of various conditions, a greater understanding of its potential for good is just now becoming apparent. And on grander scales.

Clinical Trials 49

Clinical Trials CBD Conditions Data 49

Veriheal

AUGUST 11, 2020

On the 17 th of July this year, a new study provides results which display cannabis as a safe and effective treatment for those with chronic pain from sickle cell disease. As a result, doctors are prescribing less opioids, which takes away from sickle cell disease patients’ options for treatment. . What Is Sickle Cell Disease?

Treatment 54

Treatment Chronic Pain Clinical Trials Patients 54

The Cannigma

OCTOBER 11, 2021

No clinical trial was used in the compilation of the study. The researchers themselves wrote that the study is the first “to document self-reported efficacy of CBG-predominant products,” and provides further indication that “CBG-predominant cannabis-based medicines should be studied in randomized controlled trials.”.

Conditions 132

Conditions Clinical Trials Chronic Pain Cannabinoids 132

Cannabis Law Report

JUNE 30, 2021

-1000s of UK athletes regularly taking CBD to manage pain, sleep disorders and anxiety – -Football, Rugby, Cricket, Hockey and Golf stars want clarity from governing bodies-. -UK The fact is that 1000s of UK athletes are choosing CBD to manage pain as an alternative to standard pharmacological treatments.

Medicine 75

Medicine Clinical Trials CBD Sleep 75

The Cannigma

JUNE 15, 2021

Close behind it — in both regards — is CBD, which despite having been studied for decades, has only become the center of a billion dollar industry in recent years. Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. CBD vs THC. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

MMJ Recs

DECEMBER 28, 2023

In recent years, a significant shift has occurred in the perception of medical marijuana, transforming it from a controversial substance to a recognized and, in some places, a legal form of medical treatment. CBD, a non-psychoactive cannabinoid, has gained attention for its anti-anxiety effects.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

CannaMD

AUGUST 26, 2020

A new review published by scientific journal, Pharmacology Biochemistry and Behavior , has found that marijuana cannabinoid, CBD, is a “promising” therapy for treating cocaine dependence. Current Cocaine Treatments. As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine.

Therapy 98

Therapy CBD Research and Development Treatment 98

TheAnswerPage

MARCH 29, 2022

Has the National Institute of Drug Abuse (NIDA) recently provided funding for a clinical trial evaluating the efficacy of a CBD product as an opioid-sparing agent for patients with radiculopathic pain? The primary efficacy outcome is a change in opioid maintenance dose from baseline to the end of the treatment period.

Clinical Trials 52

Clinical Trials Safety Medicine Treatment 52